Xylo Technologies Ltd., was incorporated in Israel on December 9, 1999. The Company is a medical device company engaged in the development, manufacture and marketing of surgical endoscopes and direct vision systems for minimally invasive medical procedures or other commercial uses. Their expertise is in the development, production and sale of innovative surgical devices with direct visualization for the treatment of gastroesophageal reflux disease, or GERD, a common disease that is primarily treated with medication (such as proton pump inhibitors) or chronic cases, routine open or laparoscopic surgery. 

XYLO(Delisted)

XYLO Profile